SCHEMBL4940396

SCHEMBL4940396

C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(O)C(=O)CC[C@@H]4[C@H]3CC[C@@]21C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 4/20 0.47
AR P10275 2/20 0.47
CYP19A1 P11511 2/20 0.46
SHBG P04278 3/20 0.45
ALDH1A1 P00352 3/20 0.45
NR3C1 P04150 3/20 0.45
ADRA1A P35348 1/20 0.45
HTR2B P41595 1/20 0.45
LMNA P02545 4/20 0.44
MAPT P10636 2/20 0.44
STS P08842 1/20 0.44
MAPK1 P28482 2/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 3/20 0.43
ABCB11 O95342 3/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HIF1A Q16665 1/20 0.43
ESR1 P03372 1/20 0.43
ADRA2A P08913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21807754 1.00 PGR (0.47) PGRARCYP19A1SHBGALDH1A1
SCHEMBL9541157 0.87 PGR (0.47) PGRARCYP19A1SHBGALDH1A1
SCHEMBL5700334 0.85 CYP19A1 (0.46) PGRARCYP19A1SHBGALDH1A1
SCHEMBL5700181 0.85 CYP19A1 (0.46) PGRARCYP19A1SHBGALDH1A1
SCHEMBL5700038 0.83 CYP19A1 (0.44) PGRARCYP19A1SHBGALDH1A1
SCHEMBL7125405 0.79 CYP19A1 (0.72) PGRARCYP19A1SHBGHTR2B
SCHEMBL151284 0.77 SHBG (0.59) ARCYP19A1SHBGALDH1A1LMNA
SCHEMBL931136 0.77 SHBG (0.59) ARCYP19A1SHBGALDH1A1LMNA
SCHEMBL9541205 0.76 PGR (0.41) PGRARCYP19A1SHBGALDH1A1
SCHEMBL9541223 0.75 PDK1 (0.43) PGRARSHBGALDH1A1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238310-A1 MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS NORTHWESTERN UNIVERSITY 2024-07-18 US disclosed
US-20210346385-A1 TASTE-MASKED DOSAGE FORMS DEEP OCEAN CAPITAL MANAGEMENT LP 2021-11-11 US disclosed
US-20210283144-A1 MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS NORTHWESTERN UNIVERSITY 2021-09-16 US disclosed
WO-2020061584-A1 TASTE-MASKED DOSAGE FORMS MSB HOLDINGS, INC. (US) 2020-03-26 WO disclosed
US-20150152348-A1 SYSTEMS AND METHODS FOR COLLECTING, TRANSPORTING AND REPURPOSING OR DESTROYING UNUSED PHARMACEUTICALS SHARPS COMPLIANCE, INC. OF TEXAS 2015-06-04 US disclosed
US-20080207601-A1 Methods of and Compositions For the Prevention of Anxiety, Substance Abuse, and Dependence HYTHIAM , INC. (US) 2008-08-28 US disclosed
US-20080075772-A1 PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS ACCU-BREAK TECHNOLOGIES, INC. 2008-03-27 US disclosed
US-20040002483-A1 Use of ester and ether derivatives of 4-hydroxy-19-norandrosterone to increase the level of the anabolic/androgenic hormone 4-hydroxy-19-nortestosterone in humans Paternoster, Mr. Vince 2004-01-01 US disclosed
US-20030199486-A1 Ester and ether derivatives of 4-hydroxy-19-nortestosterone and a method for the regulation of athletic function in humans NUTRI SPORT PHARMACAL, INC. (US) 2003-10-23 US disclosed